Research and Markets: Bladder Cancer Therapeutics - Global Strategic Business Report
TMCnet - World's Largest Communications and Technology Community
 
| More
TMCnews
[March 11, 2010]

Research and Markets: Bladder Cancer Therapeutics - Global Strategic Business Report

DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/2aca55/bladder_cancer_the) has announced the addition of the "Bladder Cancer Therapeutics - Global Strategic Business Report" report to their offering.



This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets.

The report profiles 56 companies including many key and niche players worldwide such as: Affitech A/S Allergan Inc.


Allos Therapeutics Inc.

Astellas Pharma Inc.

Astrazeneca Plc AVI BioPharma Inc.

BioCancell Therapeutics Inc.

Bioniche Life Sciences Inc.

Bristol-Myers Squibb Company Celldex Therapeutics Inc.

Cytavis BioPharma GMBH Eli Lilly and Company Endo Pharmaceuticals Holdings Inc.

ENKAM Pharmaceuticals A/S F. Hoffmann-La Roche Ltd.

Halozyme Therapeutics Inc.

Laboratoires Pierre Fabre SA NatImmune A/S Oncogenex Pharmaceuticals Inc.

OncoTherapy Science Inc.

Sanofi-Aventis Spectrum (News - Alert) Pharmaceuticals Inc.

Telormedix SA Viventia Biotechnologies Inc.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. Executive Summary 1. INDUSTRY OVERVIEW 2. MAJOR TRENDS & ISSUES 3. BLADDER CANCER TREATMENT 4. MAJOR BLADDER CANCER DRUGS 5. AN OVERVIEW OF BLADDER CANCER 6. RESEARCH & DEVELOPMENT 7. FDA APPROVALS AND FILINGS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT GLOBAL PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. UNITED STATES 2. JAPAN 3. EUROPE IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/2aca55/bladder_cancer_the

[ Back To TMCnet.com's Homepage ]


Featured White Papers
Top Stories
Related VoIP News

blog comments powered by Disqus


Upcoming Events

October 1- 4, 2012
The Austin Convention Center
Austin, Texas
October 1- 4, 2012
The Austin Convention Center
Austin, Texas
October 1- 4, 2012
The Austin Convention Center
Austin, Texas

DevCon5 provides you with the information and tools you need to exploit the capabilities of revolutionary HTML5 technology
View all >>

Subscribe FREE to all of TMC's monthly magazines. Click here now.